Regulatory Body Receives Joint Request for Waivers and Expedited Review of Certain Pharmaceutical Applications

Summary

The FDA has received a joint request from pharmaceutical companies Pfizer and BioNTech for waivers and expedited treatment of their COVID-19 vaccine applications, following recent regulatory developments.